Reuven J. Schore

MedStar National Rehabilitation Hospital

Also affiliated with Children's National, George Washington University, Center for Cancer and Blood Disorders, National Cancer Institute, National Institutes of Health Clinical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma”.

Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

Blood Advances(2021)10.1182/bloodadvances.2021005343

N/A

0.641DataRank · unranked

19 citations

Madeline Terpilowski, Mimi Mai, Keri Toner, Melanie Grant, Maja Stanojević +12 more

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial

Pediatric Blood & Cancer(2025)10.1002/pbc.31584

N/A

0.165DataRank · unranked

2 citations

Eric S. Schafer, Yueh‐Yun Chi, Jemily Malvar, Kenneth Heym, Andrew E. Place +22 more

Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease

Blood Advances(2025)10.1182/bloodadvances.2025017837

N/A

0.104DataRank · unranked

1 citations

Anupam Verma, Shelton A. Viola, Todd A. Alonzo, Yicheng Wang, Lisa Eidenschink Brodersen +15 more

Prognostic impact of minimal residual disease at the end of consolidation in NCI standard‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2021)10.1002/pbc.28929

N/A

0DataRank · unranked

13 citations

Yunfeng Dai, Meenakshi Devidas, Karen R. Rabin, Patrick A. Zweidler‐McKay, Anne Angiolillo +12 more

Effects of age, obesity, and body surface area on asparaginase-associated toxicities during acute lymphoblastic leukemia induction therapy: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7000

N/A

0DataRank · unranked

6 citations

Olga Militano, Zhiguo Chen, Meenakshi Devidas, Luke Maese, Rachel E. Rau +13 more

Assessment of proxy‐reported responses as predictors of motor and sensory peripheral neuropathy in children with B‐lymphoblastic leukemia

Pediatric Blood & Cancer(2023)10.1002/pbc.30634

N/A

0DataRank · unranked

3 citations

Natalie DelRocco, Emily Hibbitts, Meenakshi Devidas, Moira K. Whitley, Caroline Mohrmann +12 more

Physical and emotional quality of life in children with B-acute lymphoblastic leukemia randomized to every 4- vs. 12-week vincristine/dexamethasone during maintenance: Children’s Oncology Group AALL0932.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10025

N/A

0DataRank · unranked

1 citations

John A. Kairalla, Emily Hibbitts, Rozalyn L. Rodwin, Meenakshi Devidas, Alexandra Dreyzin +10 more

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report

Leukemia(2024)10.1038/s41375-024-02166-1

N/A

0DataRank · unranked

22 citations

Mignon L. Loh, Michael J. Borowitz, Sumit Gupta, Karen R. Rabin, Patrick A. Zweidler‐McKay +26 more

Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia

Research Square(2024)10.21203/rs.3.rs-5292018/v1

N/A

0DataRank · unranked

3 citations

Emily Ashcraft, Ti‐Cheng Chang, Kathryn G. Roberts, Samuel W. Brady, Yiping Fan +22 more

Diminished Quality of Life Despite Reduced Treatment in Children with B-Lymphoblastic Leukemia: Children’s Oncology Group AALL0932

PubMed Central(2025)10.22541/au.175344126.66272705/v1

N/A

0DataRank · unranked

0 citations

John A. Kairalla, Emily Hibbitts, Rozalyn L. Rodwin, Meenakshi Devidas, Alexandra Dreyzin +10 more

Outcomes in children with Down syndrome (DS) and B-lymphoblastic leukemia (B-ALL): A Children’s Oncology Group (COG) report.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10510

N/A

0DataRank · unranked

7 citations

Zhiguo Chen, Meenakshi Devidas, Johann Hitzler, Eric Larsen, Michael J. Burke +14 more

Caregivers’ Perspectives on Changes in Family Life During B‐ALL Therapy: A Qualitative Study From the Children's Oncology Group

Pediatric Blood & Cancer(2025)10.1002/pbc.32057

N/A

0DataRank · unranked

0 citations

Megan E. Ware, Katrina Stumbras, John A. Kairalla, Emily Hibbitts, Brenna Mossman +13 more

Outcomes with reduced intensity therapy in a low-risk subset of children with National Cancer Institute (NCI) standard-risk (SR) B-lymphoblastic leukemia (B-ALL): A report from Children’s Oncology Group (COG) AALL0932.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10509

N/A

0DataRank · unranked

6 citations

Anne Angiolillo, John A. Kairalla, Meenakshi Devidas, Karen R. Rabin, Patrick A. Zweidler‐McKay +15 more

The genomic landscape of juvenile myelomonocytic leukemia

UNC Libraries(2020)10.17615/mrye-5404

N/A

0DataRank · unranked

0 citations

Ariel Yu, Chip Stewart, Joseph F. Costello, Kimo C. Stine, Elliot Stieglitz +27 more